Search by Drug Name or NDC

    NDC 43066-0014-01 Oxaliplatin 5 mg/mL Details

    Oxaliplatin 5 mg/mL

    Oxaliplatin is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is OXALIPLATIN.

    Product Information

    NDC 43066-0014
    Product ID 43066-014_e75a145f-a175-4f01-9313-1de8665ab926
    Associated GPIs 21100028002025
    GCN Sequence Number 059162
    GCN Sequence Number Description oxaliplatin VIAL 50 MG/10ML INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 24699
    HICL Sequence Number 016687
    HICL Sequence Number Description OXALIPLATIN
    Brand/Generic Generic
    Proprietary Name Oxaliplatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Oxaliplatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name OXALIPLATIN
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078817
    Listing Certified Through 2024-12-31

    Package

    NDC 43066-0014-01 (43066001401)

    NDC Package Code 43066-014-01
    Billing NDC 43066001401
    Package 1 VIAL, SINGLE-USE in 1 CARTON (43066-014-01) / 10 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2018-02-19
    NDC Exclude Flag N
    Pricing Information N/A